856 Tofacitinib is a potential treatment for Blau syndrome by suppressing the induction of NOD2 expression
| Autor: | Ueki, Y., Takimoto-Ito, R., Saito, M.K., Tanizaki, H., Kambe, N. |
|---|---|
| Zdroj: | In Journal of Investigative Dermatology May 2023 143(5) Supplement:S147-S147 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|